Literature DB >> 10982157

Meningiomas in Singapore: demographic and biological characteristics.

A Das1, W Y Tang, D R Smith.   

Abstract

We sought to determine the relative incidence of meningiomas compared to other central nervous system tumours in an Asian surgical series, as well as the demographic and biological characteristics of these meningiomas. A review of 655 consecutive cases of central nervous system tumours from 583 patients representing the last five years admissions to one hospital in Singapore was undertaken. A total of 33 malignant/atypical tumours from 19 patients and 196 benign meningiomas from 187 patients were identified. Twenty malignant/atypical and 20 benign tumours were selected at random and subjected to histochemical and immunohistochemical analysis using antibodies directed against p53, bax and 3'-DNA hydroxy groups (TUNEL). Meningiomas comprised some 35.2% of all central nervous system tumours with malignant/atypical meningiomas representing 9.2% of meningiomas. Histochemically, necrosis was the predominant finding. However, peri-necrotic areas displayed p53 positivity in 10% of cases and bax positivity in 25% of cases. Apoptotic cells were detected in the peri-necrotic areas in 90% of benign and 75% of malignant/atypical meningiomas. Meningiomas represent the predominant form of central nervous system tumour in the Singaporean population, and aberration of p53 expression is not associated with tumour formation or progression. There was a slight but non-significant reduction in apoptosis in the progression from benign to malignant meningioma, suggesting that in contrast to many other tumour types disruption of cellular apoptosis is not a predominant driving force in Asian meningioma tumourigenesis.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10982157     DOI: 10.1023/a:1006484829159

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  30 in total

1.  Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures.

Authors:  S M Hsu; L Raine; H Fanger
Journal:  J Histochem Cytochem       Date:  1981-04       Impact factor: 2.479

Review 2.  The yin and yang of p53 in cellular proliferation.

Authors:  W Deppert
Journal:  Semin Cancer Biol       Date:  1994-06       Impact factor: 15.707

3.  Expression of p53, MDM2 protein and Ki-67 antigen in recurrent meningiomas.

Authors:  M Ohkoudo; H Sawa; M Hara; K Saruta; T Aiso; R Ohki; H Yamamoto; E Maemura; Y Shiina; M Fujii; I Saito
Journal:  J Neurooncol       Date:  1998-05       Impact factor: 4.130

Review 4.  Regulation of p53 downstream genes.

Authors:  W S el-Deiry
Journal:  Semin Cancer Biol       Date:  1998       Impact factor: 15.707

5.  Expression of Bax and bcl-2 proteins, regulators of programmed cell death, in human brain tumors.

Authors:  A Hara; Y Hirose; N Yoshimi; T Tanaka; H Mori
Journal:  Neurol Res       Date:  1997-12       Impact factor: 2.448

6.  Apoptosis is associated with atypical or malignant change in meningiomas. An in situ labelling and immunohistochemical study.

Authors:  H K Ng; L Chen
Journal:  Histopathology       Date:  1998-07       Impact factor: 5.087

7.  Statistical analysis of central nervous system tumors in China.

Authors:  H Wen-qing; Z Shi-ju; T Qing-sheng; H Jian-qing; L Yu-xia; X Qing-zhong; L Zi-jun; Z Wen-cui
Journal:  J Neurosurg       Date:  1982-04       Impact factor: 5.115

Review 8.  Relationship of p53 to the control of apoptotic cell death.

Authors:  M Oren
Journal:  Semin Cancer Biol       Date:  1994-06       Impact factor: 15.707

9.  Hypoxia induces accumulation of p53 protein, but activation of a G1-phase checkpoint by low-oxygen conditions is independent of p53 status.

Authors:  T G Graeber; J F Peterson; M Tsai; K Monica; A J Fornace; A J Giaccia
Journal:  Mol Cell Biol       Date:  1994-09       Impact factor: 4.272

Review 10.  Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis.

Authors:  M S Greenblatt; W P Bennett; M Hollstein; C C Harris
Journal:  Cancer Res       Date:  1994-09-15       Impact factor: 12.701

View more
  3 in total

1.  Diffusion-weighted MR imaging: diagnosing atypical or malignant meningiomas and detecting tumor dedifferentiation.

Authors:  V A Nagar; J R Ye; W H Ng; Y H Chan; F Hui; C K Lee; C C T Lim
Journal:  AJNR Am J Neuroradiol       Date:  2008-03-20       Impact factor: 3.825

2.  Genomic and Molecular Characterization of Brain Tumors in Asian and Non-Asian Patients of Los Angeles: A Single Institution Analysis.

Authors:  Courtney Duong; Thien Nguyen; John P Sheppard; Vera Ong; Lawrance K Chung; Daniel T Nagasawa; Isaac Yang
Journal:  Brain Tumor Res Treat       Date:  2017-10-31

3.  Atypical Growth Pattern of an Intraparenchymal Meningioma.

Authors:  Zhen Zeng; Tijiang Zhang; Yihua Zhou; Xiaoxi Chen
Journal:  Case Rep Radiol       Date:  2016-09-26
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.